




Clear associations between demographic and psychosocial factors and health-related quality of life in patients with early inflammatory joint complaints.  
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Key Messages
	Patients with early inflammatory joint complaints in primary care experience a significant reduction in health related quality of life (HR-QoL), with notably pain, reduced physical function, and reduced role functioning due to physical problems.
	Clinical characteristics together explained 4%-9% of the differences in HR-QoL among patients, whereas demographic and psychosocial characteristics explained an additional 21%-29%. 
	Passive behavioral coping with pain by reducing activities was strongly associated with HR-QoL. A one standard deviation increase in passive behavioral coping was related to 10% more pain and a reduction of 12% in physical functioning.

Policy implications
	Physicians in primary care should be aware of the fact that among patients with early inflammatory joint complaints, clinical characteristics are less important than demographic and psychosocial characteristics in perceived general health. 








To identify demographic and psychosocial characteristics associated with health-related quality of life (HR-QoL) in patients with early inflammatory joint complaints.
Methods. 
In this cross-sectional study, patients were included with inflammatory joint complaints present for less than 12 months. Data collection included clinical characteristics, demographics, life-style, behavioral coping, perceived health control, and social support. HR-QoL was assessed by 8 dimensions of the Short Form-36 Health Survey. Multiple regression analysis was used to determine the associations between clinical, demographic, life-style, and psychosocial characteristics with HR-QoL. 
Results. 
In total, 359 patients were included, of which 24% were classified as RA, 34% as mono- or oligo/poly arthritis, and 42% as inflammatory joint complaints without clinical synovitis. Among all patients, the health dimensions physical function, physical role functioning and bodily pain were most affected. The diagnostic group, erythocyte sedimentation rate (ESR), disease duration, and comorbidity explained 4%-9% of the variance in HR-QoL dimensions, whereas the combined demographic and psychosocial characteristics explained an additional 21%-29% of HR-QoL. HR-QoL was negatively associated with younger age, lower education, non-Dutch origin, passive behavioral coping with pain, lower perceived health control, and low social support. Passive behavioral coping with pain was strongest associated with HR-QoL. 
Conclusion.  
In patients with early inflammatory joint complaints, HR-QoL is stronger associated with personal characteristics than with clinical characteristics. From the onset of complaints onwards, physicians should take psychosocial factors and demographics into account to obtain an optimal disease outcome.
INTRODUCTION 
Patients with inflammatory joint complaints often present with comparable clinical signs and symptoms, despite different underlying pathologies and prognosis. Health related quality of life (HR-QoL) and restrictions in function differ among patients from disease onset onwards1. As clinical characteristics, which are targeted by physicians during treatment, cannot fully explain differences in HR-QoL2, 3, other characteristics must play a role. Since one of the main goals of treatment is to maintain an optimal HR-QoL4, insight in these characteristics is important for disease management. According to the model of the International Classification of Function, Disability and Health (ICF), HR-QoL is influenced by clinical characteristics, but also by personal and environmental factors. Personal factors include demographic, life style and psychosocial characteristics5. In patients with long-standing RA, a reduced health status has been related to older age, female sex, lower education6, low socio-economic status7, unemployment6 7, and a variety of psychosocial characteristics including low perceived health control8, low self-efficacy in handling the disease8, 9, passive behavioural coping10, 11, and low social support10, 12. Since most research studied RA patients with longstanding disease, it is largely unknown whether these demographic and psychosocial characteristics already exert their influence on health during the early phase of inflammatory joint complaints. Besides, it seems that the demographic and psychosocial factors related to a reduced health in RA patients are generic factors related to health in a broad spectrum of rheumatic diseases8, 13. However, similarities in the association between demographic and psychosocial characteristics, and health among diagnostic groups have insufficiently been studied.   








The present cross-sectional study presents the first baseline assessments of the Rotterdam Early Arthritis CoHort (REACH). REACH is an ongoing inception cohort study with four years of follow-up. REACH aims to study the etiopathogenesis, diagnostic strategies, and outcome of patients with inflammatory joint complaints for less than 12 months. General practitioners and rheumatologists (1 university hospital, 2 general hospitals) in the greater area of Rotterdam have invited patients to participate in REACH from July 2004 onwards. Data collection includes a large array of detailed medical examination and questionnaires. When patients enter the study, they can choose to provide only limited medical data and/or self-reported questionnaires. For the present study, data were available for patients who were sent by general practitioners or rheumatologists for inclusion in this study up to July 2006. This time period was chooses to ensure follow-up studies would include the same study population. 
General practitioners selected patients with arthritis in at least one joint or patients experiencing complaints in at least two joints without synovitis. The general practitioners ascertained that complaints existed for less than 12 months and were not due to trauma/mechanical problems. In addition, subjects had to be older than 16 years. During an interview by telephone and subsequent medical examination by a rheumatologist, the inclusion criteria were verified. Patients were included if 1) joint complaints existed for less than 12 months with no requirement of a minimum duration, and, 2) arthritis in at least one joint or complaints in at least two joints in combination with at least two of the following criteria ascertained during medical examination by a member of the REACH team: morning stiffness longer than one hour, bilateral compression pain in MCP or MTP, symmetrical presentation, positive family history, non-fitting shoes, non-fitting rings, pins and needles in fingers, or unexplained fatigue for less than 1 year, and, 3) complaints were predominantly present in the morning and at night, and improved with movement. Patients were excluded if 1) complaints were due to trauma/mechanical problems, 2) age was under 16 years old, 3) no written communication was possible in Dutch, or 3) a prior diagnosis of rheumatoid arthritis, ankylosing spondylitis, Sjögren’s syndrome, systemic lupus erythematosus or juvenile arthritis had been made by a rheumatologist before inclusion in this study.
For patients directly visiting rheumatologists, a similar verification procedure was applied. For all patients, enrolled through general practitioners or rheumatologists, a rheumatologist set the diagnosis.




The patients with inflammatory joint complaints were classified into three mutually exclusive diagnostic groups based on the diagnosis made by a rheumatologist; 1) definite or probable rheumatoid arthritis (RA), 2) specified or non-specified mono- or oligo/poly arthritis, non-RA, and 3) inflammatory joint complaints without apparent synovitis. Swollen joint count (SJC) (44 joints) was assessed and categorized into no synovitis, 1-2 swollen joints, and 3 or more swollen joints. Since diagnostic group and SJC were strongly related (r=0.66), only diagnostic group was included in the statistical analysis. Erythrocyte sedimentation rate (ESR)(mm/hour) was measured and classified into low (<10 mm/hr), intermediate (10-25 mm/hr) and high (>25 mm/hr) on the basis of tertile scores. ESR values were regarded as absent if measured more than two weeks apart from the physical examination (n= 39). The duration of inflammatory complaints was defined as the period between symptom onset and medical examination. Based on the median number of weeks since complaint onset, disease duration was classified as short or long. A broad range of comorbidities was ascertained, including lung disease, cardiovascular diseases, diabetes mellitus, cancer, gastrointestinal diseases, kidney diseases, diseases of the gall bladder and liver, diseases of the thyroid gland, neurological diseases, and psychiatric disease. If one or more comorbidities existed, patients were classified as having a comorbid condition (yes/no).

Demographic characteristics and life style
Age, sex, and ethnicity were asked. Ethnicity was defined by the country of birth of the mother if both parents were born abroad or by the country of birth of the parent that was born abroad15. Two categories were made, e.g. Dutch citizens (no parent born abroad) and non-Dutch citizens (at least one parent born abroad). Education was categorized according to the highest level attained into low ( 9 years: primary school, lower and intermediate secondary schooling or lower vocational training), intermediate (10-14 years: higher secondary schooling or intermediate vocational training), and high (15 years: higher vocational training or university). Employment status was defined as having paid employment (yes/no). Marital status was ascertained, and patients were classified as living alone or living with others. 
Body mass index was calculated by weight in kilograms divided by the square of the height in meters and categorized into normal (<25 kg/m2), overweight (25-30 kg/m2), and obese (>30 kg/m2). Smoking was expressed by current smoking status (yes/no).

Psychosocial characteristics
Behavioral coping was assessed by two scales of the Coping of Rheumatic Stressors (CORS) questionnaire. The scale ‘decreasing activity to cope with pain’ was measured by 8 items on a four-point scale (seldom or never, sometimes, often, very often) and similarly the scale ‘pacing to cope with limitations’ was measured by 10 items. Sum scores were computed which ranged from 8-32 and 10-40 respectively. A higher sum score indicates more frequent use of the coping strategy. Both scales have good internal consistency and high test-retest reliability 16-18. In the present study, Cronbach’s alpha for decreasing activity to cope with pain was 0.86, and Cronbach’s alpha for pacing was 0.92. Since both scales were highly correlated (r=0.77), only ‘decreasing activities to cope with pain’ was included in the statistical analysis as it was considered to be most relevant in patients with early joint complaints11, 17.
	Perceived control over health outcomes was measured by the Multidimensional Health Locus of Control Questionnaire (MHLC). The MHLC assesses three different dimensions of perceived health control by means of three scales (Cronbach’s alpha 0.68 to 0.78). The ‘internal’ scale reflects the believe that people are personally responsible for their own health, the ‘physician’ scale reflects that a physician is responsible for one’s health, and the ‘chance’ scale reflects the believe that health depends on chance, luck or fate. Each scale contains 6 statements with answers on a 6-point scale (strongly disagree to strongly agree)19, 20. The subscale scores range from 6 to 36 with a higher score indicating that a patient believes stronger in the particular health locus of control. The scales are not opposite ends of the same spectrum, and it is possible to have for example both internal and physician believes about health status at the same time. In this study, correlations among the subscales were low (r=0.01-0.33), and Cronbach’s alpha was 0.49 to 0.76.
	Social support was assessed by a subscale of the Inventory for Social Support (ISB), which is part of the Impact of Rheumatic diseases on General health and Lifestyle questionnaire (IRGL). The subscale reflects the perceived availability of emotional and instrumental support and has a documented reliability of Cronbach’s alpha of 0.8810, 21. The scale consists of five items with answers on a 4-point scale (almost never, sometimes, regularly, often) and the sum score ranges from 5 to 20 with higher scores indicating that more social support is experienced (Cronbach’s alpha 0.90). Due to the highly skewed distribution of this scale, the sum score was categorized into two categories based on the median score (low/high). 
The correlations among the psychosocial factors decreasing activity to cope with pain, perceived health control and social support were low (Spearman  r=0.00 to 0.35).
	
Health-related quality of life
Health-related quality of life was assessed by the Short Form-36 Health Survey (SF-36). The SF-36 is a generic 36-item questionnaire covering eight dimensions; physical functioning (PF), physical role functioning (PR), social functioning (SF), emotional role functioning (ER), mental health (MH), vitality (VI), bodily pain (BP), and general health (GH)22, 23. From the eight separate dimensions of the SF-36, component summary scores were calculated to provide a global measure of physical (PCS) and mental (MCS) functioning. The 8 dimensions and two summary scores may range from 0 to 100, and a higher score indicates a better HR-QoL. In order to evaluate the HR-QoL among patients in the study population, a comparison was made with a random sample from the Dutch general population24. Due to a strong ceiling effect, the dimensions emotional role functioning and physical role functioning were not included in the statistical analysis.

Statistical analysis
In the statistical analysis, differences between continuous variables were tested with the unpaired Student t-test and differences among frequencies with the chi-square test (χ2). Associations between continuous variables and between variables on an ordinal scale were studied with respectively Pearson correlation and Spearman rank correlation coefficient. The level of statistical significance was defined as p 0.05. The internal consistency of measurement scales was expressed by Cronbach’s alpha.
	Multiple linear regression analysis was conducted to determine the associations between clinical, demographic, life style, and psychosocial characteristics with six subscales of the SF-36 and the two component summary scores. The following procedure was applied to identify characteristics associated with each scale of the SF-36. First, 6 blocks of inter-related variables were defined; (1) the demographic characteristics age, sex, and ethnicity, (2) education and employment status, (3) the clinical characteristics diagnostic group, ESR, duration of complaints, and co morbidity, (4) the life-style factors smoking and BMI, (5) behavioral coping with pain and perceived health control, and (6) social support and marital status. The analysis started with multivariate regression models within each block to determine which independent variables in each block of interrelated determinants were of interest to consider in the final model. Variables with a p-value below 0.20 were selected for further investigation. Subsequently, starting with the variables selected in the previous step, final multivariate regression models were constructed. In the final regression models with scales of the SF-36 as dependent variables, independent variables with a p-value below 0.05 for at least one scale of the SF-36 were retained in all models, as well as age and sex by default. In order to compare the influence of variables with a different scale, standardized regression coefficients were also calculated, expressing the influence of a shift of one standard deviation in the scale of the variables on the outcome of interest.    





Table 1 describes the characteristics of 359 patients with early inflammatory joint complaints. About 24% of the study population was diagnosed as RA (n=86) and 35% (n=124) was classified as (non-RA) arthritis. In 39 out of 124 patients (31%) with non-RA arthritis, mono-arthritis was found, in 62 patients (50%) oligoarthritis, and 23 patients (19%) polyarthritis. Patients classified as inflammatory joint complaints without clinical synovitis (n= 149) were diagnosed with artralgia/myalgia (n= 49), inflammatory joint complaints without clinical synovitis, without further specification (n= 47), osteoarthritis (n= 37), and others (n=16). Diagnostic group was strongly associated with swollen joint count (r= 0.66). At least one comorbidity was present in 50% of the patients. Cardiovascular (24%) and respiratory disease (11%) were the most prevalent. 
Figure 2 presents the scores on the subscales of the SF-36. Compared to the Dutch reference population, patients experienced notably worse physical function, physical role functioning, and bodily pain. For physical role functioning, 44% of the patients reported the minimum score of 0, whereas 61% of the patients reported the maximum score of 100 for emotional role functioning. The interrelations among the subscales physical functioning, pain, general health, vitality, social functioning, and mental health were 0.30 to 0.62, with the lowest association between bodily pain and mental health (r=0.30) and the highest association between vitality and social functioning (r= 0.62). The correlation between physical functioning and bodily pain was 0.59.  
In Table 2 the associations of the SF-36 with blocks of interrelated clinical, demographic, life style, and psychosocial characteristics are given. Physical function was 15.7 points worse in patients with high levels of ESR, and score for bodily pain was 9.3 points worse. In all subscales of the SF-36, significant worse HR-QoL was reported by patients with a non-Dutch origin (6.0 to 13.8 points lower score) and by patients more decreasing activity to cope with pain. The following characteristics were not associated with HR-QoL (p>0.20); smoking, obesity/overweight, and marital status (Table 2). 
In the final multivariate linear regression analysis, diagnostic group, ESR, disease duration, and comorbidity together explained 4%-9% of the variance in the subscales of the SF-36, whereas adding demographic and psychosocial characteristics to the model increased the explained variance with 21%-29%, to the total explained variance in HR-QoL of 25% to 36% (Table 3). For the physical (PCS) and mental (MCS) component summary scores, clinical factors explained respectively 11% and 5% of the variance, while demographic and psychosocial factors explained an additional 28% and 17% of the variance in HR-QoL.  
Table 4 shows that the score on the dimensions physical functioning, pain, general health, vitality, social functioning, and mental health, decreased by 0.8 to 2.5 points with an increase of one unit in the coping style ‘decreasing activity to cope with pain’. Adjusted for other factors, an increase in the score on this coping style of one standard deviation (in this study population equal to 4.7 points) was associated with a 11.6 points worse score for physical functioning and a 9.6 points worse score for bodily pain. For several dimensions of HR-QoL, younger age, non-Dutch origin, low educational level, lower perceived health control and low social support were also associated with poor HR-QoL (Table 4). A worse PCS score was significantly associated with intermediate or high ESR levels, more decreasing activity to cope with pain, and more attributing health to chance. A lower MCS score was associated with high ESR levels, more decreasing activity to cope with pain and low social support. 
The observed associations between education, behavioral coping, and social support, and HR-QoL did not differ significantly among diagnostic groups, or patients with different ESR levels, when interaction terms were added to the final multivariate models. Moreover, similar results were found when RA patients were compared to both other diagnostic groups, or when swollen joint count instead of diagnostic group was included in the analysis. The number of comorbidities was only significantly associated with the subscale general health, with two or more comorbidities being associated with worse general health than one or no comorbidity.

DISCUSSION
Health-related quality of life among patients with early inflammatory joint complaints was strongly associated with demographic and psychosocial characteristics, and to a lesser extent with clinical characteristics. Diagnostic group, ESR, disease duration and comorbidity explained 4%-9% of the variance in HR-QoL dimensions, whereas the combined demographic and psychosocial characteristics explained an additional 21%-29%. In addition to well-know factors such as age, ethnicity and education, we found that behavioral coping, perceived health control and social support were related with health. 
	Patients seeking care with early inflammatory joint complaints reported notably reduced physical function, reduced role functioning due to physical problems, and increased pain compared to the reference population, irrespective of their specific diagnosis. The pattern in scores on the SF-36 resembled the pattern in restrictions generally found in patients with chronic rheumatic diseases24-26. Within this pattern in HR-QoL, the differences among patients in the extent to which the complaints intruded upon health were stronger associated with personal factors than with clinical factors. This aligns well with the biopsychosocial model27. The personal factors related to health in this study population have previously been described in patients with various chronic rheumatic conditions6, 8, 13, 26. Therefore, the present study extents these previous findings by showing that already in an early stage of disease, well-known demographic factors and behavioural coping with pain, perceived health control, and social support are stronger related to HR-QoL than clinical factors. In addition, the associations between psychosocial and demographic characteristics and health seem to be generic across different diagnostic groups, at least in an early phase of disease. 
	A similar pattern of associations between demographic and psychosocial factors and dimensions of the SF-36 was found for those SF-36 dimensions that were strongly related. Among the psychosocial factors, behavioural coping was of major influence. A one standard deviation increase in the coping style decreasing activities to cope with pain resulted in 10% more pain and a reduction of 12% in physical functioning. Behavioral coping is thought to be relatively stable over time, and may be independent of disease activity and duration13. In addition, passive behavioural coping with pain has been related to subsequent worse outcome in RA patients10, 11, 17. It could therefore be hypothesized that it is more likely that passive behavioural coping has resulted in a reduced health, than a reduced health inducing a passive coping style. However, due to the cross-sectional design of this study, reversed directionality cannot be excluded and, thus, no assumption on causation can be made. In agreement with our findings for behavioral coping, more internal and less external perceived health control was related to better health. Previous studies have shown that low perceived health control and high helplessness feelings can unfavourably affect outcome in chronic rheumatic conditions8, 28, 29. Besides, in chronic pain patients, external attribution of health has been related to ineffective coping styles to control pain, and to avoiding increasing activity to cope with pain30. 
In this cross-sectional study, the baseline data of an ongoing inception cohort study, REACH, were used. Since the prevalence of inflammatory joint complaints in the general population is unknown, little insight exists in potential selection processes during referral of patients by physicians to this inception cohort study. If selection bias has occurred, it seems that physicians are more likely to have notified patients for REACH if patients reported serious complaints. Additional analysis showed that entering the study via notification by a general practitioner or a rheumatologist did not contribute to reported differences in health.  Furthermore, due to the response of 85% after inclusion, we are confident that a response bias has not influenced the results of this study to a large extent. Individuals’ self-report tendencies may have influenced our findings, since both the psychosocial factors and HR-QoL were self-reported measures. However, the correlations among the psychosocial factors behavioral coping, health locus of control, and social support were low. Furthermore, these psychosocial factors did not have associations of similar magnitude across all SF-36 dimensions. Therefore, we think that individuals’ self-report tendencies did not importantly contribute to an overestimation of the associations. The analyses we presented did not take physical health into account when characteristics related to the mental dimensions of HR-QoL were studied, and vica versa. However, additional analysis showed that taking these constructs into account did not affect the essence of our findings. 
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Table 1 Characteristics of patients with early inflammatory joint complaints (n= 359)

Characteristics 	Rheumatoid arthritis(n=86)	(Non-RA) arthritis, specified and non-specified (n= 124)	Inflammatory joint complaints without clincal synovitis (n= 149)
ClinicalDuration of complaints (weeks) (median, IQR)Swollen joint count (44 joints) (median, IQR)ESR (mm/hr) (median, IQR)Comorbidity (%)DemographyAge (yrs) (mean, SD)Female (%)Non-Dutch citizens (%)Education (%)   Low   Intermediate   HighPaid employment (%)Marital status (% living alone)Life style Smoking (%) BMI (%)   Normal (<25 kg/m2)   Overweight (25-30 kg/m2)   Obese (>30 kg/m2)Psychosocial factorsDecreasing activities to cope with pain (8-32) (mean, SD)Pacing to cope with limitations (10-40) (mean, SD)Perceived health control (mean, SD)   Intern (6-36)    Physician (6-36)    Chance (6-36) Social support (5-20) (median, IQR) Health-related Quality of Life (0-100) (mean, SD)Physical functioningPhysical roleBodily painGeneral HealthVitalityEmotional roleSocial functioningMental HealthPhysical component summary scoreMental component summary score	16 (17)4.0 (6.5)25 (27)49%53 (14)72%22%58%27%15%56%13%30%41%36%23%15.8 (5.0)22.8 (7.1)20.1 (4.5)20.7 (4.1)20.0 (4.6)17.0 (8.0)56 (24)28 (36)39 (19)53 (18)56 (20)63 (43)70 (26)71 (19)          33 (9)51 (12)	11(18)2.0 (3.0)22 (30)44%50 (15)57%17%56%33%11%59%20%28%35%49%16%15.7 (4.7)22.3 (6.7)20.8 (5.0)19.8 (4.1)19.7 (5.5)17.5 (6.5)60 (25)39 (41)44 (22)60 (19)57 (20)72 (42)70 (27)71 (24)36 (10)51 (11)	18 (20)0 (0)8 (10)54%48 (13)86%19%52%27%21%60%14%28%41%38%21%15.0 (4.6)20.5 (6.5)19.9 (5.1)19.1 (3.9)20.1 (5.5)17.0 (7.0)65 (21)40 (40)47 (19)54 (18)54 (20)72 (41)73 (23)70 (18)               37 (9)50 (11)








Table 2. The associations within groups of clinical, demographic, life-style, and psychosocial characteristics, with scales of the SF-36 in multivariate linear regression analyses in patients with early inflammatory joint complaints.
Characteristics	PF(0-100)	BP(0-100)	GH(0-100)	VI(0-100)	SF(0-100)	MH(0-100)
RA vs IJC without clinical synovitis(Non-RA) arthritis vs IJC without clinical synovitisIntermediate ESR (10-25) vs low ESR (<10) δHigh ESR (>25) vs low ESR (<10) δDuration of complaints (long vs short)Co morbidity	-3.320.32-5.39#-15.7*1.21-0.67	-3.511.39-5.29#-9.28*7.00*-1.58	0.066.97*0.12-5.12#0.46-6.17*	3.906.20*2.01-4.63#3.13#-1.77	1.411.621.23-7.90*4.39#-2.97	2.342.123.64#-0.423.30#-4.92*
Age (yrs)Sex (male vs female)Ethnicity (non-Dutch vs Dutch citizens)	-0.10-0.51-8.49*	-0.010.34-6.03*	0.041.16-6.10*	0.26*4.00#-7.94*	0.13#-1.49-13.8*	0.08-0.61-10.2*
Intermediate vs low educationHigh vs low educationEmployment	3.299.79*2.87	2.4710.0*0.61	-2.471.644.14*	-2.406.82*-2.22	0.212.052.19	-0.803.181.20
SmokingOverweight vs normalObese vs normal	-1.46-2.11-5.29#	0.060.13-2.30	0.291.64-2.95	-0780.82-1.93	-0.79-1.440.79	0.110.002.21
Decreasing activity to cope with pain (8-32)Intern perceived health control (6-36)Physician perceived health control (6-36)Chance perceived health control (6-36)  	-2.59*0.28-0.54#-0.32#	-2.08*0.21-0.06-0.46*	-1.21*0.69*-0.71*-0.58*	-1.91*0.130.33-0.07	-2.65*0.20-0.34-0.36#	-0.94*0.07-0.75*-0.22
Marital status (alone vs with others)Social support (high vs low) 	-1.354.16#	-0.470.19	-2.885.19*	-4.06#7.27*	-1.617.25*	0.4110.1*


PF= physical functioning, BP= bodily pain, GH= general health, VI= vitality, SF=social functioning, MH= mental health
IJC= Inflammatory joint complaints
*p0.05, # p0.20, δ mm/hour

Table 3. Explained variance (R2) in scales of the SF-36 by groups of characteristics in multivariate linear regression analysis in patients with early inflammatory joint complaints.

Characteristics	PFR2	BPR2	GHR2	VIR2	SFR2	MHR2
Clinical(diagnostic group, ESR, disease duration, comorbidity)	9%	9%	7%	4%	4%	4%
Clinical + demography (+ age, sex, ethnicity, education) 	11%	13%	11%	12%	9%	9%
Clinical + demography + psychosocial factors(+ decreasing activity to cope with pain, perceived health control, social support)	34%	36%	30%	31%	33%	25%









Clinical Diagnosis   RA vs IJC without clinical synovitis   (Non-RA) arthritis vs IJC without clinical synovitis ESRδ   Intermediate (10-25) vs low (<10)   High (>25) vs low (<10)Duration of complaints (long vs short)Comorbidity (yes vs no)	-3.90-0.95-3.89-7.94*0.013.23	-4.120.92-4.80-3.606.35*0.89	-0.595.78*0.59-2.100.39-5.56*	2.555.04*0.90-2.593.08-1.60	1.231.060.84-1.743.37-0.54	2.431.043.592.112.25-3.25
DemographyAge (yrs)Sex (male vs female) Ethnicity (non-Dutch vs Dutch citizens)Education           Intermediate vs low    High vs low	0.06-0.78-2.632.284.11	0.09-1.78-1.561.147.50*	0.25*-0.87-0.06-3.78-1.66	0.29*3.14-2.56-1.174.26	0.21*-2.94-7.02*0.40-0.97	0.19*-0.26-6.80*0.601.66
Psychosocial factorsDecreasing activities to cope with pain (8-32) Perceived health control      Intern (6-36)     Physician (6-36)      Chance (6-36)Social support (high vs low)	-2.44*0.37-0.26-0.343.09	-2.03*0.240.41-0.54*0.46	-0.93*0.68*-0.92*-0.60*4.02*	-1.71*0.090.27-0.055.83*	-2.46*0.22-0.27-0.39 6.56*	-0.76*0.11-0.82*-0.258.99*





















Figure 1. Inclusion of patients with early inflammatory joint complaints 
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